image
Healthcare - Biotechnology - NASDAQ - US
$ 86.88
-3.66 %
$ 6.06 B
Market Cap
-31.14
P/E
BALANCE SHEET
732 M ASSETS
51.80%
31.8 M LIABILITIES
63.35%
701 M EQUITY
51.32%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Nuvalent, Inc.
image
Current Assets 726 M
Cash & Short-Term Investments 720 M
Receivables 0
Other Current Assets 6.58 M
Non-Current Assets 5.9 M
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 5.9 M
Current Liabilities 31.8 M
Accounts Payable 9.27 M
Short-Term Debt 0
Other Current Liabilities 22.5 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019
ASSETS
Cash & Cash Equivalents 335.4 241.8 68.5 10.3 3.0
Short Term Investments 384.5 230.4 219.6 0 0
Receivables 0 0 0 0 0
Inventory 0 0 0 0 0
Other Current Assets 6.6 5.8 5.0 0.6 0.6
Total Current Assets 726.5 478.0 290.6 10.6 3.3
PP&E 0 0 0 0 0
Intangible Assets 0 0 0 0 0
Goodwill 0 0 0 0 0
Long Term Investments 0 0 0 0 0
Other Long Term Assets 5.9 4.5 3.2 0 0
Other Assets 0 0 0 0 0
Total Assets 732.4 482.5 293.8 10.6 3.3
LIABILITIES
Accounts Payable 9.3 7.2 2.9 1.3 0.7
Short Term Debt 0 0 0 0 0
Other Current Liabilities 22.5 12.3 5.9 3.1 3.6
Total Current Liabilities 31.8 19.5 8.8 4.4 4.4
Long Term Debt 0 0 0 2.2 2.2
Deferred Tax Income 0 0 0 0 0
Other Liabilities 0 0 0 35.4 14.0
Total Liabilities 31.8 19.5 8.8 42.0 20.6
EQUITY
Common Stock 7 K 6 K 5 K 280 1
Retained Earnings (286.3) (160.1) (78.2) (31.9) (17.3)
Other Accumulative Comprehensive Income/Loss 31 K (0.5) (0.2) 280 (14.0)
Total Equity 700.6 463.0 285.0 (31.3) (17.3)
Total Liabilities and Equity 732.4 482.5 293.8 10.6 3.3
SHARES OUTSTANDING
Common Shares Outstanding 58.2 49.7 48.3 48.3 48.3